Stocks
Amgen (AMGN) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 691.9% | 547.6% | 473.7% | 473.7% | 430.2% | 562.5% | |||
| Changes by years, y/y, % | +26pp | -144pp | -74pp | 0pp | -44pp | -3.2% | |||
Amgen. R&D/CAPEX, %
Amgen. R&D/CAPEX, changes, pp
Amgen (AMGN) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 410.7% | 435.1% | 616.1% | 616.1% | 583.9% | 562.5% | ||
| Changes by years, y/y, % | -12pp | -260pp | +227pp | +227pp | +276pp | |||
| Changes by quarters, q/q, % | +103pp | +24pp | +181pp | 0pp | -32pp | |||
